**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

 

**FORM 10-Q**

 

**QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended March 31, 2008

 

Commission File Number 033-19411-C

 

 

| **TETRIDYNSOLUTIONS,INC.**                                                         |
|------------------------------------------------------------------------------------|
| (Exact name of registrant as specified in its charter)                             |
|                                                                               |
| **Nevada**                                                                         | **20-5081381** |
| (State or other jurisdiction of incorporation or organization)                     | (I.R.S. Employer Identification No.) |
|                                                                               |
| **1651 Alvin Ricken Drive, Pocatello, ID 83201**                                   |
| (Address of principal executive offices)                                           |
|                                                                               |
| **(208) 232-4200**                                                                 |
| (Registrant’s telephone number)                                              |
|                                                                               |
| **n/a**                                                                            |
| (Former name, former address and former fiscal year, if changed since last report) |

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

| Yes | x | No | o |
|-----|---|----|---|

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

| Large accelerated filer o | Accelerated filer **o**     |
|--------------------------------|----------------------------------|
| Non-accelerated filer o   | Smaller reporting company x |

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

 

| Yes | o | No | x |
|-----|---|----|---|

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.**As of May 13, 2008, issuer had 21,381,863 outstanding shares of common stock, par value $0.001.**

 

----

**TABLE OF CONTENTS**

 

 

|                                     | **Page**                                                                      |
|------------------------------------------|-------------------------------------------------------------------------------|
|                                     |                                                                          |
| **PART I – FINANCIAL INFORMATION** |                                                                          |
|                                     | Item 1. Financial Statements.                                                 | 3 |
|                                     | Condensed Consolidated Balance Sheets (Unaudited)                             | 3 |
|                                     | Condensed Consolidated Statements of Operations (Unaudited)                   | 4 |
|                                     | Condensed Consolidated Statements of Cash Flows (Unaudited)                   | 5 |
|                                     | Notes to Condensed Consolidated Financial Statements (Unaudited)              | 6 |
|                                     | Item 2. Management’s Discussion and Analysis of Financial Condition and |   |
|                                     | Results of Operations..                                                       | 11 |
|                                     | Item 3. Quantitative and Qualitative Disclosures about Market Risk            | 17 |
|                                     | Item 4T. Controls and Procedures                                              | 18 |
|                                     |                                                                          |   |
| **PART II – OTHER INFORMATION**    |                                                                          |
|                                     | Item 6. Exhibits                                                              | 18 |
|                                     | Signature                                                                     | 18 |

 

 

2

----

**PART I – FINANCIAL INFORMATION**

 

**ITEM 1. FINANCIAL STATEMENTS**

 

| **TETRIDYN SOLUTIONS, INC. AND SUBSIDIARIES**   |
|-------------------------------------------------|
| **CONDENSED CONSOLIDATED BALANCE SHEETS**       |
|                                            |
|                                            |   | **March 31,** |   | **December 31,** |
|                                            |   | **2008** |   | **2007** |
|                                            |   | **(Unaudited)** |   | **(Audited)** |
| **ASSETS**                                      |   |   |   |   |
| **Current Assets**                              |   |   |   |   |
| Cash                                            |   | $       239,601  |   | $       148,934  |
| Accounts receivable, net                        |   | 4,955  |   | 818  |
| Inventory                                       |   | 3,125  |   | -  |
| Prepaid expenses                                |   | 6,884  |   | 10,184  |
| **Total Current Assets**                        |   | 254,565  |   | 159,936  |
| **Property and Equipment, net**                 | 44,352  |   | 45,264  |
| **Deferred Offering Costs**                     |   | 12,230  |   | 11,951  |
| **Total Assets**                                |   | $       311,147  |   | $       217,151  |
|                                            |   |   |   |   |
| **LIABILITIES**                                 |   |   |   |   |
| **Current Liabilities**                         |   |   |   |   |
| Accounts payable                                |   | $       48,033  |   | $         56,801  |
| Accrued liabilities                             |   | 63,260  |   | 73,469  |
| Unearned revenue                                |   | 60,138  |   | 57,803  |
| Notes payable, current portion                  | 190,482  |   | 222,531  |
| **Total Current Liabilities**                   |   | 361,913  |   | 410,604  |
| **Long-Term Liabilities**                       |   |   |   |   |
| Notes payable, net of current portion           | 308,480  |   | 318,647  |
| **Total Long-Term Liabilities**                 |   | 308,480  |   | 318,647  |
| **Total Liabilities**                           |   | 670,393  |   | 729,251  |
|                                            |   |   |   |   |
| **NON-CONTROLLING INTEREST**                    | 400,976  |   | 157,940  |
|                                            |   |   |   |   |
| **STOCKHOLDERS' DEFICIT**                       |   |   |   |   |
| Preferred stock - $0.001 par value              |   |   |   |
| Authorized:                                     | 5,000,000 shares |   |   |   |
| Issued:                                         | no shares | -  |   | - |
| Common stock - $0.001 par value                 |   |   |   |
| Authorized:                                     | 100,000,000 shares |   |   |   |
| Issued and outstanding:                         | 21,011,863 shares and |   |   |   |
|                                            | 21,011,863 shares, respectively | 21,012  |   | 21,012  |
| Additional paid-in capital                      |   | 2,576,710  |   | 2,576,710  |
| Deferred stock compensation                     |   | -  |   | (13,286) |
| Accumulated deficit                             |   | (3,357,944) |   | (3,254,476) |
| **Total Stockholders' Deficit**                 |   | (760,222) |   | (670,040) |
| **Total Liabilities and Stockholders' Deficit** | $       311,147  |   | $       217,151   |

 

See the accompanying notes to condensed consolidated financial statements.

 

3

 

 

----

| **TETRIDYN SOLUTIONS, INC. AND SUBSIDIARIES**           |
|---------------------------------------------------------|
| **CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**     |
| **(Unaudited)**                                         |
|                                                    |   |   |   |
|                                                    | **For the Three Months Ended** |
|                                                    | **March 31,** |
|                                                    | **2008** |   | **2007** |
| **Revenue**                                             | $  343,705  |   | $     283,492  |
| **Cost of Revenue**                                     | 130,971  |   | 96,123  |
| **Gross Profit**                                        | 212,734  |   | 187,369  |
| **Operating Expenses**                                  |   |   |   |
| General and administrative                              | 80,254  |   | 50,223  |
| Professional fees                                       | 43,682  |   | 92,999  |
| Selling and marketing                                   | 54,842  |   | 63,849  |
| Research and development                                | 290,347  |   | 21,843  |
| **Total Operating Expenses**                            | 469,125  |   | 228,914  |
| **Net Loss from Operations**                            | (256,391) |   | (41,545) |
| **Other Income (Expenses)**                             |   |   |   |
| Non-Controlling Interest in Investee's                  |   |   |   |
| Net (Income)/Loss                                       | 161,879  |   | -  |
| Interest Income                                         | 73  |   | 81  |
| Interest Expense                                        | (9,029) |   | (15,179) |
| **Total Other Income (Expenses)**                       | 152,923  |   | (15,098) |
| **Net Profit (Loss) before Provision for Income Taxes** | (103,468) |   | (56,643) |
| **Provision for Income Taxes**                          | - |   | - |
| **Net Profit (Loss)**                                   | $(103,468) |   | $    (56,643) |
|                                                    |   |   |   |
| **Basic and Diluted Loss Per Common Share**             | $      (0.00) |   | $        (0.00) |
|                                                    |   |   |   |
| **Basic and Diluted Weighted-Average**                  |   |   |   |
| **Common Shares Outstanding**                           | 21,011,863  |   | 20,381,931  |

 

See the accompanying notes to condensed consolidated financial statements.

 

4

 

----

| **TETRIDYN SOLUTIONS, INC. AND SUBSIDIARIES**                                                         |
|-------------------------------------------------------------------------------------------------------|
| **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**                                                   |
| **(Unaudited)**                                                                                       |
|                                                                                                  |   |   |   |
|                                                                                                  | **For the Three Months Ended** |
|                                                                                                  | **March 31,** |
|                                                                                                  | **2008** |   | **2007** |
| **Cash Flows from Operating Activities**                                                              |   |   |   |
| Net Loss                                                                                              | $       (103,468) |   | $         (56,643) |
| Adjustments to reconcile net loss to net cash provided by   (used in) operating activities: |   |   |   |
| Depreciation                                                                                          | 2,787  |   | 3,149  |
| Common stock issued for services                                                                      | 13,286  |   | 65,352  |
| Non-controlling interest in investee                                                                  | 243,036  |   | -  |
| Changes in operating assets and liabilities:                                                          |   |   |   |
| Accounts receivable                                                                                   | (4,137) |   | (1,365) |
| Inventory                                                                                             | (3,125) |   | -  |
| Prepaid expenses                                                                                      | 3,300  |   | -  |
| Deferred offering costs                                                                               | (279) |   | -  |
| Accrued expenses                                                                                      | (10,209) |   | 3,196  |
| Accounts payable                                                                                      | (8,768) |   | (29,325) |
| Unearned revenue                                                                                      | 2,335  |   | 5,176  |
| **Net Cash Provided by (Used in) Operating Activities**                                               | 134,758  |   | (10,460) |
| **Cash Flows from Investing Activities**                                                              |   |   |   |
| Purchase of property and equipment                                                                    | (1,875) |   | -  |
| **Net Cash Used in Investing Activities**                                                             | (1,875) |   | -  |
| **Cash Flows from Financing Activities**                                                              |   |   |   |
| Principal payments on notes payable                                                                   | (42,216) |   | (11,760) |
| Proceeds from issuance of common stock                                                                | -  |   | 450  |
| **Net Cash Used in Financing Activities**                                                             | (42,216) |   | (11,310) |
| **Net Increase (Decrease) in Cash**                                                                   | 90,667  |   | (21,770) |
| **Cash at Beginning of Period**                                                                       | 148,934  |   | 81,723  |
| **Cash at End of Period**                                                                             | $         239,601  |   | $           59,953  |
|                                                                                                  |   |   |   |
| **Supplemental Disclosure of Cash Flow Information:**                                                 |   |   |   |
| Cash paid for income taxes                                                                            | $                     -  |   | $                     -  |
| Cash paid for interest expense                                                                        | $             8,665  |   | $           11,787  |

 

See the accompanying notes to condensed consolidated financial statements.

 

5

 

----

**TETRIDYN SOLUTIONS, INC. AND SUBSIDIARY**

**Notes to the Condensed Consolidated Financial Statements**

(Unaudited)

 

**Note 1 – Basis of Presentation**

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the Securities and Exchange Commission for interim financial information. Accordingly, they do not include all the information necessary for a comprehensive presentation of financial position and            results of operations.

 

It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments) have been made that are necessary for a fair financial statements presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year. The interim consolidated financial statements should be read in conjunction with the            Company’s annual report on Form 10-KSB for the year ended December 31, 2007, including the financial statements and notes thereto.

 

**Note 2 – Organization and Summary of Significant Accounting Policies**

 

***Nature of Business***– TetriDyn Solutions, Inc. (the “Company”) and its wholly owned and controlled subsidiaries specialize in providing business information technology (IT) solutions to its customers. The Company optimizes business and IT processes by utilizing systems engineering methodologies, strategic planning and guidance, and system            integration to add efficiencies and value to its customers’ business processes.

 

***Principles of Consolidation –***The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, an Idaho corporation also named TetriDyn Solutions, Inc., and results of operations of its 39.2% owned variable interest entity, Southfork Solutions, Inc. Intercompany accounts and transactions have been eliminated in            consolidation (see Notes 4 and 5).

 

***Business Segments –***The Company’s services can be broadly classified into two principal segments: the business IT solutions segment and the livestock segment. The business IT solutions segment primarily provides business IT solutions within the healthcare industry, although the segment is in the process of expanding the solutions to other selected            industries including education and professional services such as legal and accounting offices. The livestock segment is focused on providing business IT solutions specifically within the livestock industry. In accordance with Statement of Financial Accounting Standards (“SFAS”) No. 131,*“Disclosures about Segments of an Enterprise and Related Information*,” the Company has evaluated the segment reporting            requirements and determined that it now has two reportable segments.

 

***Use of Estimates –***In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the            reported period. Actual results could differ from these estimates.

 

***Cash and Cash Equivalents –***For purposes of the cash flow statements, the Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.

 

6

 

 

----

***Revenue Recognition –***The Company’s AeroMD EMR, or electronic medical records, software is provided as turnkey software that has been customized for specific medical specializations. The Company typically installs the software at the customer’s location for a fee and charges the customer a monthly license fee, based on the number of operating            workstations, under a one- or two-year usage agreement. The customer is entitled to all systems upgrades during the one- or two-year license. At the end of their contracts, customers may continue using AeroMD by entering into a new license with the Company. The Company also sells installation and post-contract telephone support service contracts on an hourly basis. The Company does not provide any rights of return or warranties on its AeroMD EMR software.

 

Revenue from software licenses and related installation and support services is recognized when earned and realizable. Revenue is earned and realizable when persuasive evidence of an arrangement exists, services, if requested by the customers, have been rendered and are determinable, and collectibility is reasonably assured. Amounts received from customers prior to these criteria being met are            deferred. Revenue from the sale of software is recognized when delivered to the customer or upon installation of the software if an installation contract exists. Revenue from post-contract telephone support service contracts is recognized as the services are provided, determined on an hourly basis. Revenue applicable to multiple-element fee arrangements is divided among the software, the installation, and post-contract support service contracts using vendor-specific objective            evidence of fair value, as evidenced by the prices charged when the software and the services are sold as separate products or arrangements.

 

The Company also provides IT management consulting services. To date, these services have been primarily in the hospital industry. These services are paid for on a monthly basis and for a flat-fee, which is not cancelable or refundable. Revenue for these services is recognized over the contract period.

 

The Company had one customer that represented 71% of sales for the three-month period ended March 31, 2008. This same customer represented 73% of sales for the three-month period ended March 31, 2007. This customer is a regional hospital that contracted with the Company for IT consulting and management services.

 

***Going Concern******–***The accompanying financial statements have been prepared on the assumption that the Company will continue as a going concern. As reflected in accompanying financial statements, the Company had a net loss of $103,468, a working capital deficiency of $107,348, and an accumulated deficit of $760,222 for the            three months ended March 31, 2008. The ability of the Company to continue as a going concern is dependent on the Company’s ability to generate increased sales and raise additional capital. The financial statements do not include any adjustments that may result from the outcome of this uncertainty.

 

***Income Taxes –***The Company utilizes the liability method of accounting for income taxes. Under the liability method, deferred tax assets and liabilities are determined based on temporary differences between financial reporting and tax bases of assets and liabilities and on the amount of operating loss carry-forwards, and are measured using the enacted tax            rates and laws that will be in effect when the temporary differences and carry-forwards are expected to reverse. An allowance against deferred tax assets is recorded when it is more likely than not that such tax benefits will not be realized.

 

***Fair Value of Financial Instruments –***The carrying amounts of the Company’s accounts receivable, restricted cash, accounts payable, notes payable, and deferred compensation approximate fair value due to the relatively short period to maturity for these instruments.

 

7

 

 

----

***Property and Equipment –***Property and equipment are recorded at cost. Maintenance, repairs, and renewals that neither materially add to the value of the property nor appreciably prolong its life are charged to expense as incurred. Property and equipment are depreciated using the straight-line method over the estimated useful lives of the assets. Gains or            losses on dispositions of property and equipment are included in the results of operations when realized.

 

***Net Loss Per Common Share –***Basic and diluted net loss per common share is computed based upon the weighted-average stock outstanding as defined by Financial Accounting Standards No. 128, “*Earnings Per Share*.” As of March 31, 2008 and 2007, 3,520,500 and 0 (zero), respectively, of common share            equivalents were antidilutive and not used in the calculation of diluted net loss per share.

 

***Stock-Based Compensation –***The Company’s shareholders approved the 2006 Long-Term Incentive Plan under which up to 4,000,000 shares of common stock may be issued. The 2006 plan is to be administered either by the board of directors or by the appropriate committee to be appointed from time to time by such board of directors. Awards granted under the 2006            plan may be incentive stock options (“ISOs”) (as defined in the Internal Revenue Code), appreciation rights, options that do not qualify as ISOs, or stock bonus awards that are awarded to employees, officers, and directors who, in the opinion of the board or the committee, have contributed or are expected to contribute materially to the Company’s success. In addition, at the discretion of the board of directors or the committee, options or bonus stock may be            granted to individuals who are not employees, officers, or directors, but contribute to the Company’s success.

 

Under SFAS No. 123R, all employee stock-based compensation is measured at the grant date, based on the fair value of the option or award, and is recognized as an expense over the requisite service, which is typically through the date the options or awards vest. The Company adopted SFAS No. 123R using the modified prospective method. Under this method, for all stock-based options and awards granted            prior to January 1, 2006, that remain outstanding as of that date, compensation cost is recognized for the unvested portion over the remaining requisite service period, using the grant-date fair value measured under the original provisions of SFAS No. 123, “*Accounting for Stock-Based Compensation,*” for pro forma and disclosure purposes. Furthermore, compensation costs will also be recognized for any awards issued,            modified, repurchased, or cancelled after January 1, 2006.

 

***Recent Accounting Pronouncements –***In September 2006, the Financial Accounting Standards Board, or FASB, issued SFAS No. 157, “*Fair Value Measurements.*” The objective of SFAS No. 157 is to increase consistency and comparability in fair value measurements and to expand disclosures about fair value            measurements. SFAS No. 157 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. SFAS No. 157 applies under other accounting pronouncements that require or permit fair value measurements and does not require any new fair value measurements. The provisions of SFAS No. 157 are effective for fair value measurements made in fiscal years beginning after November 15, 2007.            The adoption of this statement did not have a material effect on the Company’s future reported financial position or results of operations.

 

In February 2007, the FASB issued SFAS No. 159, “*The Fair Value Option for Financial Assets and Financial Liabilities – Including an Amendment of FASB Statement No. 115.*” This statement permits entities to choose to measure many financial instruments and certain other items at fair value. Most of the provisions of SFAS No. 159 apply            only to entities that elect the fair value option. However, the amendment to SFAS No. 115, “*Accounting for Certain Investments in Debt and Equity Securities,*” applies to all entities with available-for-sale and trading securities. SFAS No. 159 is effective as of the beginning of an entity’s first fiscal year that begins after November 15, 2007. Early adoption is permitted as of the beginning of a fiscal year            that begins on or before November 15, 2007, provided the entity also elects to apply the provisions of SFAS No. 157*.*The adoption of this statement did not have a material effect on the Company’s financial statements.

 

8

 

 

----

In December 2007, the FASB issued SFAS No. 160, “*Noncontrolling Interests in Consolidated Financial Statements – an amendment of ARB No. 51.*” This statement improves the relevance, comparability, and transparency of the financial information that a reporting entity provides in its consolidated financial statements by establishing            accounting and reporting standards that require the ownership interests in subsidiaries held by parties other than the parent and the amount of consolidated net income attributable to the parent and to the noncontrolling interest be clearly identified and presented on the face of the consolidated statement of income, changes in a parent’s ownership interest while the parent retains its controlling financial interest in its subsidiary be accounted for consistently, when a            subsidiary is deconsolidated, any retained noncontrolling equity investment in the former subsidiary be initially measured at fair value, and entities provide sufficient disclosures that clearly identify and distinguish between the interests of the parent and the interests of the noncontrolling owners. SFAS No. 160 affects those entities that have an outstanding noncontrolling interest in one or more subsidiaries or that deconsolidate a subsidiary. SFAS No. 160 is effective for            fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2008. Early adoption is prohibited. The adoption of this statement is not expected to have a material effect on the Company’s financial statements.

 

In March 2008, the FASB issued SFAS No. 161, “*Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No.* *133.*” This statement is intended to improve transparency in financial reporting by requiring enhanced disclosures of an entity’s            derivative instruments and hedging activities and their effects on the entity’s financial position, financial performance, and cash flows. SFAS No. 161 applies to all derivative instruments within the scope of SFAS No. 133, “*Accounting for Derivative Instruments and Hedging Activities*” as well as related hedged items, bifurcated derivatives, and nonderivative instruments that are designated and qualify as hedging            instruments. Entities with instruments subject to SFAS No. 161 must provide more robust qualitative disclosures and expanded quantitative disclosures. SFAS No. 161 is effective prospectively for financial statements issued for fiscal years and interim periods beginning after November 15, 2008, with early application permitted. We are currently evaluating the disclosure implications of this statement.

 

***Reclassifications –***Certain amounts in the 2007 information have been reclassified to conform to the 2008 presentation. These reclassifications had no impact on the Company’s net loss or cash flows.

 

**Note 3 – Inventory**

 

Although the Company does not typically carry inventory, in January 2008, the Company purchased one third-party software package valued at $3,125 which it still has in its inventory.

 

**Note 4 – Variable Interest Entities**

 

In December 2003, the FASB issued a revision to Interpretation No. 46, “*Consolidation of Variable Interest Entities”*(“FIN No. 46R”), which was originally issued in January 2003. FIN No. 46R provides guidance on the consolidation of certain entities when control exists through means other than ownership of voting (or similar)            interests and was effective for public entities that have interests in variable interest entities commonly referred to as special purpose entities for the first reporting period that ends after March 15, 2004. FIN No. 46R requires consolidation by the majority holder of expected residual gains and losses of the activities of a variable interest entity (“VIE”).

 

9

 

 

----

As of March 31, 2008, the Company owned 39.2% of the voting interest in Southfork Solutions, Inc., an Idaho corporation. Southfork Solutions’ objective is to provide electronic livestock verification and tracking throughout the entire livestock lifecycle. In July 2007, the Company entered into an agreement with Southfork Solutions. The agreement details the stock compensation that Southfork            Solutions will pay to the Company for management services, as well as cash compensation that Southfork Solutions will pay to the Company for technical services, including but not limited to engineering, marketing, bookkeeping, and administration. According to the agreement, Southfork Solutions will compensate the Company with 45,000 common shares per month for management services and with cash based upon hours spent for all other services. In addition, Southfork Solutions has            consulting agreements for consulting services to be paid with Southfork Solutions’ common stock in the collective amount of 24,450 shares per month. Southfork Solutions also accepted the final installment of $210,000 cash toward the $500,000 investment from Five Rivers Cattle Feeding, LLC in March 2008; Five Rivers Cattle Feeding received 210,000 shares of Southfork Solutions’ common stock in exchange for the final installment. The Company’s ownership in Southfork            Solutions was 39.6% as of January 1, 2008.

 

The Company has concluded that Southfork Solutions meets the definition of a VIE because the Company has an agreement with Southfork Solutions to fully manage and control the financial direction of Southfork Solutions and is the primary beneficiary of its operations.

 

The effect of the VIE’s consolidation on the Company’s consolidated balance sheet at March 31, 2008, was an increase in the Company’s assets and liabilities of $189,757 and $5,163, respectively. The Company also recognized non-controlling interest net loss of $161,879 for the three months ended March 31, 2008.

 

**Note 5 – Segment Reporting**

 

The Company operates in two reportable segments in 2008 based on differences in services provided. The Company only had one segment in the first three months of 2007 and therefore, no segment information is presented for that period. The business IT solutions segment primarily provides IT services and products to a variety of industries, whereas the livestock segment is focused on delivering services            and products specifically to the livestock industry.

 

The accounting policies of the segments are the same as those described in “Organization and Summary of Significant Accounting Policies” above. Segment data includes intersegment revenues. Assets and costs of the corporate headquarters are allocated to the segments based on usage. The Company’s business is currently conducted principally in the United States.

 

The following table summarizes segment information for the three months ended March 31, 2008:

 

|                                       | **Business IT Solutions** |    | **Livestock** |   | **Eliminations** |   | **Consolidated** |
|--------------------------------------------|---------------------------|---------|---------------|--------|------------------|--------|------------------|
|                                       |                      |    |          |   |             |   |             |
| **Three Months Ended**

**March 31, 2008** |                      |    |          |   |             |   |             |
| External revenues                          | $                         | 343,705 |          | $      | --          |   | $                | --  |   | $ | 343,705  |
| Intersegment revenues                      |                      | 442,450 |          |   | --          |   |             | (442,450) |   |   | --  |
| General and administrative expense         |                      | 77,975  |          |   | 2,279       |   |             | --  |   |   | 80,254  |
| Professional fees expense                  |                      | 42,325  |          |   | 1,357       |   |             | --  |   |   | 43,682  |
| Research & development expense         |                      | 27,822  |          |   | 262,525     |   |             | --  |   |   | 290,347  |
| Intersegment expenses                      |                      | --      |          |   | 442,450     |   |             | (442,450) |   |   | --  |
| Net income (loss)                          |                      | 814     |          |   | (104,282)        |   |             | --  |   |   | (103,468) |
| Total assets                               |                      | 121,390 |          |   | 189,757     |   |             | --  |   |   | 311,147  |
| Total liabilities                          |                      | 665,230 |          |   | 5,163       |   |             | --  |   |   | 670,393  |

 

 

10

 

----

**Note 6 – Subsequent Event**

 

In April 2008, the Company granted 60,000 shares of common stock to each of its two outside directors for their services valued at the fair value on the date of grant of $12,000 total for both directors. The Company also granted 250,000 shares of common stock to a consultant for services rendered valued at the fair value on the date of grant of $25,000. Also in April 2008, the Company granted            1,887,500 stock options to employees and executives, and directors. Stock option compensation expense will be the estimated fair value of options granted amortized on a straight-line basis over the requisite service period for the entire portion of the award.

 

**ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

 

The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and notes to our financial statements included elsewhere in this report. This discussion contains forward-looking statements that involve risks and uncertainties. Actual results could differ materially from those anticipated in these forward-looking statements as a result of various            factors discussed elsewhere in this report.

 

Certain information included herein contains statements that may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements relating to our anticipated revenues, gross margin and operating results, estimates used in the preparation of our financial            statements, future performance and operations, plans for future expansion, capital spending, sources of liquidity, and financing sources. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future, and accordingly, such results may differ from those expressed in any forward-looking statements made herein. These risks and uncertainties include those relating to our liquidity requirements, the continued            growth of the software and IT services industries, the success of our product-development, marketing and sales activities, vigorous competition in the software industry, dependence on existing management, leverage and debt service (including sensitivity to fluctuations in interest rates), domestic or global economic conditions, the inherent uncertainty and costs of prolonged arbitration or litigation, and changes in federal or state tax laws or the administration of such            laws.

 

**Overview**

 

We optimize business and information technology (IT) processes by utilizing systems engineering methodologies, strategic development, and integration to add efficiencies and value to our customers’ business processes. Our business was founded as an Idaho corporation, TetriDyn Solutions, Inc. On March 22, 2006, we completed a share exchange with Creative Vending Corp., then inactive, that            resulted in TetriDyn Solutions, Inc. becoming a wholly owned subsidiary of the Florida corporation, the legal acquirer. For accounting purposes, the Idaho corporation was the accounting acquirer because its management and controlling shareholders continued to manage and control the consolidated enterprise following the exchange. In June 2006, we changed our corporate domicile from Florida to Nevada and changed our name from Creative Vending Corp. to TetriDyn Solutions,            Inc.

 

Our business IT solutions segment provides IT solutions to the healthcare industry, but we are expanding our business IT solutions to selected other industries. We provide small-to-midsize businesses with a cost-effective conduit to an array of advanced IT engineering skills from management to engineering to basic technical assistance.

 

11

 

 

----

Our livestock segment capitalizes on our healthcare industry experience in our business IT solutions segment along with the core technology in our AeroMD EMR software to develop, implement, and market products and services that will provide electronic livestock verification and tracking throughout the lifecycle of an animal and its by-products.

 

**Description of Expenses**

 

General and administrative expenses consist primarily of salaries and related costs for accounting, administration, finance, human resources, and information systems for internal use.

 

Professional fees expenses consist primarily of fees related to legal, outside accounting, auditing, and investor relations services.

 

Selling and marketing expenses consist primarily of advertising, promotional activities, trade shows, travel, and personnel-related expenses.

 

Research and development expenses consist of payroll and related costs for software engineers, management personnel, and the costs of materials and equipment used by these employees in the development of new or enhanced product offerings.

 

In accordance with Financial Accounting Standards Board, or FASB, Statement of Financial Accounting Standards (“SFAS”) No. 86, “*Accounting for the Costs of Computer Software to be Sold, Leased or Otherwise Marketed,”*development costs incurred in the research and development of new software products to be sold, leased, or            otherwise marketed are expensed as incurred until technological feasibility in the form of a working model has been established. Internally generated, capitalizable software development costs have not been material to date. We have charged our software development cost to research and development expense in our statements of operations.

 

Property and equipment are recorded at cost. Maintenance, repairs, and renewals that neither materially add to the value of the property nor appreciably prolong its life are charged to expense as incurred. Property and equipment are depreciated using the straight-line method over the estimated useful lives of the assets. Gains or losses on dispositions of property and equipment are included in the            results of operations when realized.

 

**Results of Operations**

 

**Comparison of Three Months Ended March 31, 2008 and 2007**

 

***Revenues***

 

Our revenue was $343,705 for the three months ended March 31, 2008, compared to $283,492 for the three months ended March 31, 2007, representing an increase of $60,213, or 21%, for the three-month period. The increase in revenues was due to an expansion in our existing consulting services to a regional hospital in August 2007, the addition of another consulting agreement with a            regional surgery center in March 2007, and increased AeroMD and third-party software sales throughout the three months ended March 31, 2008.

 

12

 

 

----

***Cost of Revenue***

 

Our cost of revenue was $130,971 for the three months ended March 31, 2008, compared to $96,123 for the three months ended March 31, 2007, representing an increase of $34,848, or 36%, for the three-month period. The gross margin percentage on revenue was 62% for the three months ended March 31, 2008, and 66% for the three months ended March 31, 2007. The decrease in the gross            margin percentage for the three months ended March 31, 2008, from the three months ended March 31, 2007, was primarily due to increased support costs on the consulting contracts.

 

Although the net changes and percent changes with respect to our revenues and our cost of revenue for the three months ended March 31, 2008 and 2007, are summarized above, the trends contained therein are limited and should not be viewed as a definitive indication of our future results.

 

***Operating Expenses***

 

General and Administrative — General and administrative expenses, including noncash compensation expense, were $80,254 for the three months ended March 31, 2008, compared to $50,223 for the three months ended March 31, 2007, representing an increase of $30,031, or 60%, for the three-month period. The increase in our general and administrative expenses for the three-month            period ended March 31, 2008, as compared to the three months ended March 31, 2007, reflects an increase in payroll costs in 2008 due to an additional administrative staff member and an increase in salaries to existing personnel. We also experienced an increase in insurance costs as well as other general expenditures.

 

Professional Fees — Professional fees expenses, including noncash compensation expense, were $43,682 for the three months ended March 31, 2008, compared to $92,999 for the three months ended March 31, 2007, representing a decrease of $49,317, or 53%, for the three-month period. The decrease in our professional fees expenses for the three-month period ended March 31, 2008, as            compared to the three months ended March 31, 2007, reflects the decrease in investor relations expenses in 2008.

 

Selling and Marketing — Selling and marketing expenses, including noncash compensation expense, were $54,842 for the three months ended March 31, 2008, compared to $63,849 for the three months ended March 31, 2007, representing a decrease of $9,007, or 14%, for the three-month period. The decrease in our selling and marketing expenses for the three-month period ended March            31, 2008, as compared to the three months ended March 31, 2007, primarily reflects a reduction of labor required for supporting our value-added resellers.

 

Research and Development Expenses — Research and development expenses were $290,347 for the three months ended March 31, 2008, compared to $21,843 for the three months ended March 31, 2007, representing an increase of $268,504, or 12,292%, for the three-month period. The increase in research and development expenses reflects significant increased research and development            activities within and in support of Southfork Solutions, which we expect to continue and possibly increase in coming months. The increased research and development activities required the addition of two engineers to our staff and also includes the stock compensation by the issuance of shares of Southfork Solutions’ common stock paid to Johnson Livestock, LLC and Dr. Scott Mac Gregor for their research and development input and facilities.

 

13

 

 

----

Interest expense was $9,029 for the three months ended March 31, 2008, as compared to $15,179 for the three months ended March 31, 2007, representing a decrease of $6,150, or 41%, for the three-month period. The decrease in interest expense related primarily to our reduction of debt on which interest was applied and lower variable interest rates in 2008.

 

**Liquidity and Capital Resources**

 

At March 31, 2008, our principal source of liquidity consisted of $239,601 of cash, as compared to $148,934 of cash at December 31, 2007. In addition, our stockholders’ deficit was $760,222 at March 31, 2008, compared to stockholders’ deficit of $670,040 at December 31, 2007, an increase in the deficit of $90,182.

 

Our operations provided net cash of $134,758 during the three months ended March 31, 2008, as compared to using $10,460 of net cash during the three months ended March 31, 2007. The $145,218 decrease in the net cash used by our operating activities primarily resulted from the reduced loss in the three months ended March 31, 2008, compared to the three months ended March 31, 2007, as well as the            inclusion of the non-controlling interest in our VIE.

 

Investing activities for the three months ended March 31, 2008, used $1,875 of net cash, as compared to no net cash used during the three months ended March 31, 2007. The increase in net cash used related to increased property or equipment purchases in the three months ended March 31, 2008.

 

Financing activities used $42,216 during the three months ended March 31, 2008, compared to using net cash of $11,310 during the three months ended March 31, 2007. The increase of $30,906 of net cash used in financing activities was primarily due to the increase in notes payable repayments in 2008.

 

We are focusing our efforts on increasing revenue while we explore external funding alternatives. We currently have contracts in place for future deliveries of our consulting services, our AeroMD product, and other solutions that we believe will cover our minimum expenditures for operating costs and minimum installments due on our other indebtedness to nonaffiliates during the next 12 months. We            expect that additional sales will enable us to increase our payments on indebtedness and support the development of other products.

 

In order for us to expand our business IT solutions customer base, increase our payments on indebtedness, and pursue the development of our Electronic Livestock Verification Information System, or ELVIS, program in our livestock segment leading to product roll-out, we will be required to increase our revenues substantially and to seek additional external capital. Our growth within ELVIS will be            severely restricted if we are unable to obtain external funding. ELVIS is currently being funded by an investor within the cattle industry through Southfork Solutions. The development of the ELVIS program and market introduction of commercial products is dependent upon the further investment by the current investor or additional external funding being raised. Investment made in Southfork Solutions directly benefits us since we are contracted to provide the management,            administrative, and research and development services to Southfork Solutions. We do not anticipate that Southfork Solutions will generate significant revenues during 2008 due to the continued research and development activities that are required.

 

On October 25, 2006, our common stock began being quoted on the OTCBB and the Pink Sheets, which we anticipate may enhance our access to equity capital. Additionally, as we continue development of new products and identify specific commercialization opportunities, we will focus on those product markets and opportunities for which we might be able to get external funding through joint venture            agreements, strategic partnerships, or other direct investments.

 

We have no significant contractual obligations or commercial commitments not reflected on our balance sheet as of this date.

 

14

 

 

----

**Critical Accounting Policies**

 

We have identified the policies outlined below as critical to our business operations and an understanding of our results of operations. The list is not intended to be a comprehensive list of all of our accounting policies. In many cases, the accounting treatment of a particular transaction is specifically dictated by accounting principles generally accepted in the United States, with no need for            management’s judgment in their application. The impact and any associated risks related to these policies on our business operations is discussed throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations where such policies affect our reported and expected financial results. For a detailed discussion on the application of these and other accounting policies, see the Notes to the December 31, 2007 Consolidated Financial Statements.            Note that our preparation of the financial statements requires us to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities at the date of our financial statements, and the reported amounts of revenue and expenses during the reporting period. There can be no assurance that actual results will not differ from those estimates.

 

**Revenue Recognition**

 

Our AeroMD EMR software is provided as turnkey software that has been customized for specific medical specializations. We typically install the software at the customer’s location for a fee and charge the customer a monthly license fee, based on the number of operating workstations, under a one- or two-year usage agreement. The customer is entitled to all systems upgrades            during the one- or two-year license. At the end of their contracts, customers may continue using AeroMD by entering into a new license with us. We also sell installation and post-contract telephone support service contracts on an hourly basis. We do not provide any rights of return or warranties on our AeroMD EMR software.

 

Revenue from software licenses and related installation and support services is recognized when earned and realizable, which is when persuasive evidence of an arrangement exists, services, if requested by the customers, have been rendered and are determinable, and collectibility is reasonably assured. Amounts billed to customers prior to these criteria being met are deferred.            Revenue from the sale of software is recognized when delivered to the customer or upon installation of the software if an installation contract exists. Revenue from post-contract telephone support service contracts is recognized as the services are provided, determined on an hourly basis. Revenue applicable to multiple-element fee arrangements is divided among the software, the installation, and post-contract support service contracts using vendor-specific objective evidence of fair            value. Fair value is evidenced by the prices charged when the software and the services are sold as separate products or arrangements.

 

We also provide IT management consulting services. To date, these services have been primarily in the hospital industry. These services are paid for on a monthly basis and for a flat-fee, which is not cancelable or refundable. Revenue for these services is recognized over the contract period.

 

**Income Taxes**

 

We utilize the liability method of accounting for income taxes. Under the liability method, deferred tax assets and liabilities are determined based on temporary differences between financial reporting and tax bases of assets and liabilities and on the amount of operating loss carry-forwards, and are measured using the enacted tax rates and laws that will be in effect when the            temporary differences and carry-forwards are expected to reverse. An allowance against deferred tax assets is recorded when it is more likely than not that such tax benefits will not be realized.

 

15

 

 

----

**Stock Based Compensation**

 

Effective January 1, 2006, we adopted the provisions of SFAS No. 123 (revised), “*Share-Based Payment*,” which replaces SFAS No. 123, “*Accounting for Stock-Based Compensation*,” and supersedes APB Opinion No. 25, “*Accounting for            Stock Issued to Employees*,” and related interpretations. SFAS No. 123R requires compensation costs related to share-based payment transactions, including employee stock options, to be recognized in the financial statements. In addition, we adhere to the guidance set forth within SEC Staff Accounting Bulletin No. 107, which provides the views of the staff of the SEC regarding the interaction between SFAS No. 123R and certain SEC rules and regulations            and provides interpretations with respect to the valuation of share-based payments for public companies.

 

In adopting SFAS No. 123R, we applied the modified prospective approach to transition. Under the modified prospective approach, the provisions of SFAS No. 123R are to be applied to new awards and to awards modified, repurchased, or cancelled after the required effective date. Additionally, compensation cost for the portion of awards for which the requisite service has not been            rendered that are outstanding as of the required effective date shall be recognized as the requisite service is rendered on or after the required effective date. The compensation costs for that portion of awards shall be based on the grant-date fair value of those awards as calculated for either recognition or pro forma disclosures under SFAS No. 123.

 

**Variable Interest Entities**

 

In December 2003, the FASB issued a revision to Interpretation No. 46,*Consolidation of Variable Interest Entities*(“FIN No. 46R”), which was originally issued in January 2003. FIN No. 46R provides guidance on the consolidation of certain entities when control exists through means other than ownership of voting (or            similar) interests and was effective for public entities that have interests in variable interest entities commonly referred to as special purpose entities for the first reporting period that ends after March 15, 2004. FIN No. 46R requires consolidation by the majority holder of expected residual gains and losses of the activities of a variable interest entity (“VIE”).

 

We have concluded that Southfork Solutions meets the definition of a VIE because we have an agreement with Southfork Solutions to fully manage and control the financial direction of Southfork Solutions and we are the primary beneficiary of its operations. Therefore, we have accounted for Southfork Solutions’ operations by consolidating them with our financials and recognizing            the non-controlling interest in their operations.

 

**Recent Accounting Pronouncements**

 

In September 2006, the FASB issued SFAS No. 157, “*Fair Value Measurements.*” The objective of SFAS No. 157 is to increase consistency and comparability in fair value measurements and to expand disclosures about fair value measurements. SFAS No. 157 defines fair value, establishes a framework for measuring fair value in generally accepted            accounting principles, and expands disclosures about fair value measurements. SFAS No. 157 applies under other accounting pronouncements that require or permit fair value measurements and does not require any new fair value measurements. The provisions of SFAS No. 157 are effective for fair value measurements made in fiscal years beginning after November 15, 2007. The adoption of this statement did not have a material effect on our future reported financial position or results of            operations.

 

16

 

 

----

In February 2007, the FASB issued SFAS No. 159, “*The Fair Value Option for Financial Assets and Financial Liabilities – Including an Amendment of FASB Statement No. 115.*” This statement permits entities to choose to measure many financial instruments and certain other items at fair value. Most of the provisions of SFAS No. 159 apply            only to entities that elect the fair value option. However, the amendment to SFAS No. 115, “*Accounting for Certain Investments in Debt and Equity Securities,*” applies to all entities with available-for-sale and trading securities. SFAS No. 159 is effective as of the beginning of an entity’s first fiscal year that begins after November 15, 2007. Early adoption is permitted as of the beginning of a fiscal year that            begins on or before November 15, 2007, provided the entity also elects to apply the provision of SFAS No. 157*.*The adoption of this statement did not have a material effect on our financial statements.

 

In December 2007, the FASB issued SFAS No. 160, “*Noncontrolling Interests in Consolidated Financial Statements – an amendment of ARB No. 51.*” This statement improves the relevance, comparability, and transparency of the financial information that a reporting entity provides in its consolidated financial statements by establishing            accounting and reporting standards that require the ownership interests in subsidiaries held by parties other than the parent and the amount of consolidated net income attributable to the parent and to the noncontrolling interest be clearly identified and presented on the face of the consolidated statement of income; changes in a parent’s ownership interest while the parent retains its controlling financial interest in its subsidiary be accounted for consistently; when a            subsidiary is deconsolidated, any retained noncontrolling equity investment in the former subsidiary be initially measured at fair value; and entities provide sufficient disclosures that clearly identify and distinguish between the interests of the parent and the interests of the noncontrolling owners. SFAS No. 160 affects those entities that have an outstanding noncontrolling interest in one or more subsidiaries or that deconsolidate a subsidiary. SFAS No. 160 is effective for            fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2008. Early adoption is prohibited. The adoption of this statement is not expected to have a material effect on our financial statements.

 

In March 2008, the FASB issued SFAS No. 161, “*Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No.* *133.*” This statement is intended to improve transparency in financial reporting by requiring enhanced disclosures of an entity’s            derivative instruments and hedging activities and their effects on the entity’s financial position, financial performance, and cash flows. SFAS No. 161 applies to all derivative instruments within the scope of SFAS No. 133, “*Accounting for Derivative Instruments and Hedging Activities*” as well as related hedged items, bifurcated derivatives, and nonderivative instruments that are designated and qualify as hedging            instruments. Entities with instruments subject to SFAS No. 161 must provide more robust qualitative disclosures and expanded quantitative disclosures. SFAS No. 161 is effective prospectively for financial statements issued for fiscal years and interim periods beginning after November 15, 2008, with early application permitted. We are currently evaluating the disclosure implications of this statement.

 

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

 

Not applicable.

 

 

17

 

 

----

**ITEM 4T. CONTROLS AND PROCEDURES**

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit to the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods specified by the Securities and Exchange Commission’s rules and            forms, and that information is accumulated and communicated to our management, including our principal executive and principal financial officers (whom we refer to in this periodic report as our Certifying Officers), as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our Certifying Officers, the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange            Act) as of March 31, 2008, pursuant to Rule 13a-15(b) under the Securities Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of March 31, 2008, our disclosure controls and procedures were effective.

 

There were no changes in our internal control over financial reporting that occurred during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

**PART II – OTHER INFORMATION**

 

**ITEM 6. EXHIBITS**

 

The following exhibits are filed as a part of this report:

 

| **Exhibit Number*** |   |  

**Title of Document**                                                                                                                                                |   |  

**Location** |
|---------------------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|----------------------|
|                |   |                                                                                                                                                                         |   |                 |
| **Item 31**         |   | **Rule 13a-14(a)/15d-14(a) Certifications**                                                                                                                                  |   |                 |
| 31.01               |   | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Rule 13a-14                                                                         |   | Attached             |
|                |   |                                                                                                                                                                         |   |                 |
| **Item 32**         |   | **Section 1350 Certifications**                                                                                                                                              |   |                 |
| 32.01               |   | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer and Chief Financial Officer) |   | Attached             |

_______________

| * | All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document. |
|---|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

**SIGNATURE**

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

|               | TETRIDYN SOLUTIONS, INC. |
|--------------------|--------------------------|
|               |                     | (Registrant) |
|               |                     |   |
| Date: May 15, 2008 | By:                      | /s/ David W. Hempstead |
|               |                     | David W. Hempstead, President,

Chief Executive Officer, and

Chief Financial Officer |

 

 

18